KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA)
CUSIP: 483119202
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 28,929,479
- Total 13F shares
- 1,734,395
- Share change
- -1,906,297
- Total reported value
- $2,653,735
- Price per share
- $1.53
- Number of holders
- 21
- Value change
- -$8,492,399
- Number of buys
- 13
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 483119202?
CUSIP 483119202 identifies KALA - KALA BIO, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 483119202:
Top shareholders of KALA - KALA BIO, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Rajeev M. Shah |
3/4/5
|
Director |
—
class O/S missing
|
10,914,613
|
$73,564,492 | — | 17 Jun 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
7,039,613
|
$47,446,992 | — | 26 May 2022 | |
| Gregory Grunberg |
3/4/5
|
Director |
—
class O/S missing
|
5,451,860
|
$36,745,536 | — | 17 Jun 2021 | |
| BAKER BROS. ADVISORS LP |
13F
3/4/5
|
Company · Former 10% owner |
1.5%
from 3/4/5
|
1,201,894
|
$5,721,015 | — | 30 Jun 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.1%
|
603,027
|
$2,870,409 | — | 30 Jun 2025 | |
| SR ONE CAPITAL MANAGEMENT, LP |
13F
|
Company |
2.1%
|
598,940
|
$2,850,954 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
1%
|
300,149
|
$1,428,709 | — | 30 Jun 2025 | |
| AIGH Capital Management LLC |
13F
|
Company |
1%
|
300,000
|
$1,428,000 | — | 30 Jun 2025 | |
| Hongming Chen |
3/4/5
|
CHIEF SCIENTIFIC OFFICER |
—
class O/S missing
|
204,515
|
$1,378,431 | — | 26 Oct 2021 | |
| ADAR1 Capital Management, LLC |
13D/G
13F
|
Company |
4.9%
|
298,955
|
$1,270,559 | $0 | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.59%
|
170,375
|
$810,985 | — | 30 Jun 2025 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.48%
|
138,556
|
$659,527 | — | 30 Jun 2025 | |
| Eric Trachtenberg |
3/4/5
|
Chief Legal Officer, Chief Compliance Officer and Secretary |
—
mixed-class rows
|
88,566
mixed-class rows
|
$458,765 | — | 04 Jan 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
56,367
|
$268,337 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.19%
|
55,227
|
$262,881 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.07%
|
21,356
|
$101,655 | — | 30 Jun 2025 | |
| Mark S. Blumenkranz |
3/4/5
|
Director |
—
mixed-class rows
|
17,517
mixed-class rows
|
$87,495 | — | 11 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.06%
|
17,400
|
$82,824 | — | 30 Jun 2025 | |
| Andrew I. Koven |
3/4/5
|
Director |
—
mixed-class rows
|
23,822
mixed-class rows
|
$68,566 | — | 15 Jun 2025 | |
| Howard B. Rosen |
3/4/5
|
Director |
—
mixed-class rows
|
21,952
mixed-class rows
|
$66,667 | — | 15 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.04%
|
12,990
|
$61,832 | — | 30 Jun 2025 | |
| Gregory D. Perry |
3/4/5
|
Director |
—
mixed-class rows
|
18,794
mixed-class rows
|
$53,909 | — | 15 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
10,399
|
$49,499 | — | 30 Jun 2025 | |
| C. Daniel Myers |
3/4/5
|
Director |
—
mixed-class rows
|
15,824
mixed-class rows
|
$41,910 | — | 15 Jun 2025 | |
| Marjan Farid |
3/4/5
|
Director |
—
mixed-class rows
|
15,692
mixed-class rows
|
$41,377 | — | 15 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,143
|
$5,441 | — | 30 Jun 2025 | |
| Covestor Ltd |
13F
|
Company |
0%
|
1,138
|
$5,000 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
972
|
$4,627 | — | 30 Jun 2025 | |
| MAI Capital Management |
13F
|
Company |
0%
|
300
|
$1,428 | — | 30 Jun 2025 | |
| Cheviot Value Management, LLC |
13F
|
Company |
—
class O/S missing
|
153
|
$1,129 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
237
|
$1,128 | — | 30 Jun 2025 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
120
|
$571 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
100
|
$476 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
98
|
$466 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
98
|
$466 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13D/G
|
— |
0%
|
257
|
$393 | -$717,340 | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
34
|
$162 | — | 30 Jun 2025 | |
| Legacy Investment Solutions, LLC |
13F
|
Company |
0%
|
25
|
$119 | — | 30 Jun 2025 | |
| Legacy Wealth Managment, LLC/ID |
13F
|
Company |
0%
|
25
|
$119 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
8
|
$38 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0%
|
7
|
$33 | — | 30 Jun 2025 | |
| Parallel Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
1
|
$5 | — | 30 Jun 2025 | |
| Robert Bradley Paull |
3/4/5
|
Director |
—
class O/S missing
|
40,000
|
— | — | 16 Jun 2022 |
Institutional Holders of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) as of Q3 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.